Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis

Anticancer Research

Volumn 27, Issue 5 B, 2007, Pages 3661-3666

  Lequerica Fernández, Paloma ^a   Astudillo, Aurora ^a,b   De Vicente, Juan Carlos ^a,b,c  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c Faculty de Medicina   (Spain)

Author keywords

Lymph node metastasis; Salivary gland carcinoma; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35348998484     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Spitz MR and Batsakis JG: Major salivary gland carcinoma - Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol 11: 45-49, 1984.
2. Lopes MA, Santos GC and Kowalski LP: Multivariate analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 20: 699-706, 1998.
3. Hickham RE, Cawson RA and Duffy SW: The prognosis of specific types of salivary gland tumors. Cancer 54: 1620-1624, 1984.
4. Spiro RH, Huvos AG and Strong EW: Cancer of the parotid gland: A clinicopathologic study of 288 primary cases. Am J Surg 130: 452-459, 1975.
5. Werner JA and Davis RK (eds.): Metastases in Head and Neck Cancer. Berlin: Springer, pp. 52 & 221, 2004.
6. Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol 13: 159-167, 2003.
7. Hiremath LS, Webb NR and Rhoads RE: Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 260: 7843-7849, 1985.
8. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
9. Ferrara N and Davis-Smith T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997.
10. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY and Hebbel RP: VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signalling. Exp Cell Res 247: 495-504, 1999.
11. Kyzas PA, Cunha IW and Ioannidis JPA: Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: A meta-analysis. Clin Cancer Res 11: 1434-1440, 2005.
12. Greene FL, Page DL and Fleming ID: AJCC Cancer Staging Manual (6th ed.). New York: Springer, 2002.
13. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP and Lim CY: Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32: 552-561, 2003.
14. Doi R, Kuratate I, Okamoto E, Ryoke K and Ito H: Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med 28: 259-263, 1999.
15. Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr and Ellis LM: Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 5: 3364-3368, 1999.
16. Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K and Yoshikawa J: Increased levels of vascular of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 33: 595-599, 2003.
17. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298, 1996.
18. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K and Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk 1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-553, 1998.
19. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099, 2005.
20. Ilhan N, Ilhan D and Deveci F: Functional significance of vascular endothelial growth factor and its receptor (receptor-I) in various lung cancer types. Clin Biochem 37: 840-845, 2004.
21. Younes MN, Park YW, Yazici YD, Gu M, Santillan AA, Nong X, Kim S, Jasser SA, El-Naggar AK and Myers JN: Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthopic nude mouse model. Mol Cancer Ther 5: 2696-2705, 2006.